116 results on '"Qudeimat, Amr"'
Search Results
2. Venetoclax-based therapy as a bridge to allogeneic hematopoietic cell transplantation in children with relapsed/refractory AML
3. Intrapulmonary administration of recombinant activated factor VII in pediatric, adolescent, and young adult oncology and hematopoietic cell transplant patients with pulmonary hemorrhage
4. Preferential expansion of CD8+ CD19-CAR T cells postinfusion and the role of disease burden on outcome in pediatric B-ALL
5. Disease Status and Interval between Hematopoietic Cell Transplantations Predict Outcome of Pediatric Patients Who Undergo Subsequent Transplantation for Relapsed Hematologic Malignancy
6. Allogeneic Hematopoietic Cell Transplantation for Acute Megakaryocytic Leukemia: A Single Center Study
7. Risk-Adapted Donor Lymphocyte Infusion after Hematopoietic Cell Transplant in Pediatric and Young Adult Patients Is Associated with Low Risk of Graft Versus Host Disease
8. Transplantation's Aftermath: Navigating the Landscape of Post-Hematopoietic Cellular Therapy Neoplasms
9. Outcomes of pediatric patients who relapse after first HCT for acute leukemia or MDS
10. Memory T-cell enriched haploidentical transplantation with NK cell addback results in promising long-term outcomes: a phase II trial.
11. 1529: NT-PROBNP AS A BIOMARKER OF ENDOTHELIOPATHY IN PEDIATRIC HEMATOPOIETIC CELL TRANSPLANTATION
12. Comparison of Haemonetics Cell Saver 5+ and manual density separation for optimum depletion of red blood cells and preservation of CD34+ cells in major ABO-incompatible bone marrow grafts
13. Interplay Effect of Splenic Motion for Total Lymphoid Irradiation in Pediatric Proton Therapy
14. Improved survival rate in T-cell depleted haploidentical hematopoietic cell transplantation over the last 15 years at a single institution
15. Sub-myeloablative Second Transplantations with Haploidentical Donors and Post-Transplant Cyclophosphamide have limited Anti-Leukemic Effects in Pediatric Patients
16. BRIEF REPORT Outcomes following intolerance to calcineurin-inhibitor based graft-versus-host disease prophylaxis in children after allogeneic hematopoietic cell transplantation
17. Second Allogeneic HCT Can Successfully Salvage a Subset of Patients Who Relapse Following First Allogeneic HCT: A Single-Center Retrospective Analysis of 108 Pediatric Patients
18. Outcomes following intolerance to calcineurin inhibitor‐based graft‐versus‐host disease prophylaxis in children after allogeneic hematopoietic cell transplantation.
19. Venetoclax-based therapy as a bridge to allogeneic hematopoietic cell transplantation in children with relapsed/refractory AML
20. CD45RA Depleted T-Cell Addback and Prophylactic Blinatumomab Administration Following Tcrαβ/CD19-Depleted Haploidentical Transplantation in Pediatric Patients with High Risk Acute Leukemia
21. CD45RA-Depleted Haploidentical Transplantation Combined with NK Cell Addback Results in Promising Long-Term Outcomes in Pediatric Patients with High-Risk Hematologic Malignancies
22. Venetoclax-Based Combination Therapy As a Bridge to Allogeneic Hematopoietic Stem Cell Transplant in Children with Relapsed/Refractory AML
23. Pulmonary Complications in Children Following Hematopoietic Cell Transplantation: A Case Report and Review of the Diagnostic Approach
24. CD45RA-Depleted Haploidentical Transplantation Combined with NK Cell Addback Results in Promising Long-Term Outcomes in Pediatric Patients with High-Risk Hematologic Malignancies
25. CD45RO+ T-Cell Add Back and Prophylactic Blinatumomab Administration Post Tcrαβ/CD19-Depleted Haploidentical Transplantation in Pediatric Patients with High Risk Acute Leukemia
26. Case Report: Management Approach and Use of Extracorporeal Membrane Oxygenation for Diffuse Alveolar Hemorrhage After Pediatric Hematopoietic Cell Transplant
27. Allogeneic Hematopoietic Cell Transplantation Is Critical to Maintain Remissions after CD19-CAR T-Cell Therapy for Pediatric ALL: A Single Center Experience
28. Bioactive Sphingolipids in Neuroblastoma
29. 558 - Second Allogeneic HCT Can Successfully Salvage a Subset of Patients Who Relapse Following First Allogeneic HCT: A Single-Center Retrospective Analysis of 108 Pediatric Patients
30. Effectiveness of Bath Wipes After Hematopoietic Cell Transplantation: A Randomized Trial
31. Second Allogeneic Hematopoietic Cell Transplant Is a Successful Salvage Modality for Pediatric Patients Who Relapse after First Transplant
32. Haploidentical CD45RA-Negative Donor Lymphocyte Infusions Are Feasible, Safe and Associated with Clinical Benefit
33. Multiple NDM-5-Expressing Escherichia Coli Isolates From an Immunocompromised Pediatric Host
34. Improved survival rate in T-cell depleted haploidentical hematopoietic cell transplantation over the last 15 years at a single institution
35. 148 - Venetoclax-Based Combination Therapy As a Bridge to Allogeneic Hematopoietic Stem Cell Transplant in Children with Relapsed/Refractory AML
36. 128 - CD45RA-Depleted Haploidentical Transplantation Combined with NK Cell Addback Results in Promising Long-Term Outcomes in Pediatric Patients with High-Risk Hematologic Malignancies
37. 41 - CD45RA Depleted T-Cell Addback and Prophylactic Blinatumomab Administration Following Tcrαβ/CD19-Depleted Haploidentical Transplantation in Pediatric Patients with High Risk Acute Leukemia
38. Autologous CD19-CAR T-Cells for the Treatment of Acute Lymphoblastic Leukemia in Pediatric and Young Adult Patients: An initial Report from an Institutional Phase I/II Study
39. Sequential Infusion of Tcrαβ- and CD45RA-Depleted Haploidentical Progenitor Cells Is Safe and Allows for Rapid Immune Reconstitution in Pediatric Patients with Recurrent Hematological Malignancies
40. Disease Status and Interval between HCTs Predict Outcome of Pediatric Patients who Undergo a Subsequent HCT for Relapsed Hematologic Malignancy
41. Infused Total Nucleated Cell Dose is a Better Predictor of Transplant Outcomes Than CD34+ Cell Dose for Peripheral Blood Allogeneic Hematopoietic Cell Transplantation in Children
42. Allogeneic Hematopoietic Cell Transplantation for Acute Megakaryoblastic Leukemia: A Single Center Experience
43. Allogeneic Hematopoietic Cell Transplantation for Acute Megakaryocytic Leukemia: A Single Center Study
44. Risk-Adapted Donor Lymphocyte Infusion after Hematopoietic Cell Transplant in Pediatric and Young Adult Patients Is Associated with Low Risk of Graft Versus Host Disease
45. Abstract B18: Role of sphingolipids and ER stress in curcumin mediated cytotoxicity In human neuroblastoma cells
46. 582 - Infused Total Nucleated Cell Dose is a Better Predictor of Transplant Outcomes Than CD34+ Cell Dose for Peripheral Blood Allogeneic Hematopoietic Cell Transplantation in Children
47. 413 - Allogeneic Hematopoietic Cell Transplantation for Acute Megakaryoblastic Leukemia: A Single Center Experience
48. Changes in Red Blood Cell Mean Corpuscular Volume after Pediatric HSCT
49. Regulation and Functional Role of Beta2-Adrenergic Receptor in Acute Myelogenous Leukemia
50. Reduced toxicity conditioning for hematopoietic stem cell transplantation in children with Diamond-Blackfan anemia.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.